Advocacy and the cancer patient viewpoint

il y a 7 ans 919 Vues

IMS Health at ISPOR - Washington DC - May 2016

il y a 7 ans 641 Vues

IMS Health Real-World Evidence Brochure

il y a 8 ans 843 Vues

AccessPoint - 9th Issue - November 2014

il y a 8 ans 476 Vues

Convergence of HTA assessments in Europe

il y a 8 ans 1013 Vues

Prospective identification of drug safety signals

il y a 8 ans 507 Vues

Facts Addressing Migraine Market Misperceptions

il y a 8 ans 12510 Vues

Enabling clinical trial expansion

il y a 8 ans 427 Vues

EMR as a highly powerful European RWD source

il y a 8 ans 30089 Vues

RWE: A new way to engage IDNs

il y a 8 ans 2578 Vues

Building innovative, effective RWE platforms

il y a 8 ans 1239 Vues

Integrate RWE into clinical development

il y a 8 ans 722 Vues

HEOR, Pharmacoepidemiology & Drug Safety

il y a 8 ans 376 Vues

IMS Health Enriched Real-World Data Study

il y a 8 ans 1539 Vues